GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,632,000 | -3.2% | 45,733 | +1.2% | 0.47% | -11.1% |
| Q4 2020 | $1,686,000 | -2.2% | 45,192 | -0.1% | 0.53% | -12.7% |
| Q3 2020 | $1,724,000 | -7.1% | 45,225 | +0.6% | 0.61% | -15.0% |
| Q2 2020 | $1,855,000 | +9.1% | 44,960 | +1.6% | 0.72% | -9.6% |
| Q1 2020 | $1,701,000 | -16.9% | 44,245 | +2.6% | 0.79% | +1.5% |
| Q4 2019 | $2,048,000 | +11.0% | 43,118 | +0.8% | 0.78% | +3.5% |
| Q3 2019 | $1,845,000 | +10.7% | 42,770 | +3.9% | 0.75% | +5.8% |
| Q2 2019 | $1,667,000 | -4.5% | 41,170 | +0.0% | 0.71% | -8.2% |
| Q1 2019 | $1,745,000 | +8.5% | 41,157 | -1.0% | 0.78% | -5.0% |
| Q4 2018 | $1,609,000 | -2.8% | 41,577 | +2.2% | 0.82% | +5.6% |
| Q3 2018 | $1,655,000 | +0.1% | 40,697 | +0.4% | 0.77% | -5.6% |
| Q2 2018 | $1,654,000 | +2.7% | 40,537 | -0.1% | 0.82% | +0.2% |
| Q1 2018 | $1,611,000 | +42.1% | 40,582 | +28.7% | 0.82% | +37.9% |
| Q4 2017 | $1,134,000 | -25.0% | 31,542 | -14.2% | 0.59% | -27.5% |
| Q3 2017 | $1,511,000 | -4.1% | 36,766 | +0.7% | 0.82% | -7.5% |
| Q2 2017 | $1,575,000 | +2.4% | 36,521 | +0.1% | 0.88% | +0.9% |
| Q1 2017 | $1,538,000 | +12.2% | 36,491 | +2.5% | 0.88% | +3.4% |
| Q4 2016 | $1,371,000 | -14.0% | 35,591 | -3.7% | 0.85% | -15.5% |
| Q3 2016 | $1,594,000 | +3.4% | 36,956 | +3.9% | 1.00% | -0.5% |
| Q2 2016 | $1,541,000 | +11.4% | 35,556 | +4.2% | 1.01% | +9.1% |
| Q1 2016 | $1,383,000 | +1.2% | 34,111 | +0.8% | 0.92% | -2.4% |
| Q4 2015 | $1,366,000 | +16.5% | 33,846 | +11.0% | 0.95% | +2.9% |
| Q3 2015 | $1,173,000 | -13.4% | 30,496 | -6.2% | 0.92% | -16.3% |
| Q2 2015 | $1,355,000 | +4.5% | 32,525 | +15.8% | 1.10% | +2.9% |
| Q1 2015 | $1,297,000 | +7.1% | 28,095 | -0.8% | 1.07% | +2.4% |
| Q4 2014 | $1,211,000 | -3.8% | 28,330 | +3.5% | 1.04% | -11.0% |
| Q3 2014 | $1,259,000 | -12.1% | 27,380 | +2.2% | 1.17% | -12.1% |
| Q2 2014 | $1,433,000 | -0.3% | 26,800 | -0.4% | 1.33% | -0.8% |
| Q1 2014 | $1,438,000 | +27.7% | 26,915 | +27.6% | 1.34% | +19.5% |
| Q4 2013 | $1,126,000 | – | 21,085 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |